国际眼科纵览 ›› 2014, Vol. 38 ›› Issue (3): 180-184.doi: 10.3760/ cma. j. issn.1673-5803.2014.03.008

• 综述 • 上一篇    下一篇

后发性白内障防治进展

万修华, 李晓霞   

  1. 100005  首都医科大学附属北京同仁医院 北京同仁眼科中心 眼科学与视觉科学北京市重点实验室 北京市眼科研究所(万修华);450006 郑州市第二人民医院眼科(李晓霞)
  • 收稿日期:2014-01-21 出版日期:2014-06-22 发布日期:2014-06-23
  • 通讯作者: 万修华,Email: xiuhuawan@126.com

Prevention and treatment of posterior capsular opacification after cataract surgery

 WAN  Xiu-Hua1, LI  Xiao-Xia2   

  1. 1Beijing Institute of Ophtholmology, Beijing Tongren Eye Center,   Beijing Key Laboratory of Ophthalmology and Visual Sciences,  Beijing Tongren Hospital,  Capital Medical University, Beijing 100005,  China;  2 Department of Ophthalmology,  The Second People's Hospital of Zhengzhou,  Henan 450006,  China
  • Received:2014-01-21 Online:2014-06-22 Published:2014-06-23
  • Contact: WAN Xiu-hua, Email: xiuhuawan@126.com

摘要: 晶状体后囊膜混浊(posterior capsular opacification,  PCO)也称后发性白内障,是白内障术后最常见的并发症。对其防治,以往研究多关注在白内障设备、操作技巧、IOL材料及设计方面,且已日臻完善。近些年更多关注PCO相关癌基因、凋亡基因等,但操作相对复杂,仅处于基础研究阶段;通过免疫手段干扰PCO发生,相对简单、廉价、可行,但效应短暂;药物治疗具有潜在的细胞毒性作用。(国际眼科纵览, 2014, 38: 180-184)

Abstract: Posterior capsular opacification(PCO) remains the most common postoperative complication after cataract surgery. Previous studies had focused on improvements in surgical instruments and techniques,  novel IOL biomaterials and IOL designs,  and had been well developed. Lately more and more studies focused on cancer and apoptosis gene research which were much complex and only at a basic research stage. Using immunological techniques interfered PCO which were simply,  cheap and feasible. And medical drugs for PCO which had potential cytotoxicity.  (Int Rev Ophthalmol, 2014, 38: 180-184)